Automate Your Wheel Strategy on ELV
With Tiblio's Option Bot, you can configure your own wheel strategy including ELV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ELV
- Rev/Share 838.1488
- Book/Share 194.2028
- PB 1.4911
- Debt/Equity 0.6904
- CurrentRatio 0.0
- ROIC 29.1255
- MktCap 65015643940.0
- FreeCF/Share 17.7192
- PFCF 16.2498
- PE 12.1633
- Debt/Assets 0.2476
- DivYield 0.0231
- ROE 0.1251
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ELV | Argus | Buy | Hold | -- | -- | July 21, 2025 |
| Downgrade | ELV | Leerink Partners | Outperform | Market Perform | -- | $310 | July 18, 2025 |
| Downgrade | ELV | Robert W. Baird | Outperform | Neutral | -- | $529 | April 15, 2025 |
| Upgrade | ELV | Argus | Hold | Buy | -- | $450 | March 17, 2025 |
| Downgrade | ELV | Stephens | Overweight | Equal Weight | $520 | $440 | Jan. 22, 2025 |
| Downgrade | ELV | Argus | Buy | Hold | -- | -- | Oct. 18, 2024 |
News
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
Published: June 09, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE:ELV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Read More
ELV Shareholders Have the Right to Lead the Elevance Health, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV
Published: June 09, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , June 9, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE: ELV) for violations of the federal securities laws. Shareholders who purchased the Company's securities between April 18, 2024 and October 16, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 11, 2025.
Read More
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: June 09, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , June 9, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE: ELV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 18, 2024 and October 16, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 11, 2025.
Read More
ELV INVESTORS: Elevance Health, Inc. Shareholders Are Reminded to Contact BFA Law Before The Expiration of The Upcoming July 11 Class Action Deadline
Published: June 06, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 6, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
Published: June 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance
Published: June 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options
Read More
ELV INVESTOR NOTICE: Elevance Health, Inc. Investors with Losses are Notified of the Ongoing Securities Fraud Class Action and July 11 Deadline – BFA Law (NYSE:ELV)
Published: June 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Read More
ELV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Elevance Health, Inc. to Contact the Firm Today!
Published: June 06, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Elevance securities between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period").
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in Elevance Health, Inc. of Class Action Lawsuit And Upcoming Deadlines - ELV
Published: June 05, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE:ELV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Read More
ELV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Elevance Health, Inc. to Contact the Firm Today!
Published: June 05, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Elevance securities between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period").
Read More
ELV LAWSUIT: Elevance Health, Inc. Lawsuit Alleges Securities Fraud Violations - Investors Notified to Contact BFA Law
Published: June 04, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / June 4, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
Published: June 04, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or the "Company") (NYSE:ELV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Read More
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance
Published: June 04, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Elevance To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Elevance between April 18, 2024 and October 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , June 4, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Elevance Health, Inc. ("Elevance" …
Read More
NYSE: ELV DEADLINE REMINDER: Berger Montague Reminds Elevance Health (NYSE: ELV) Investors of Important Class Action Lawsuit Deadline
Published: June 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
PHILADELPHIA, June 04, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) on behalf of purchasers of Elevance securities between April 18, 2024 through October 16, 2024, inclusive (the “Class Period”).
Read More
ELV LAWSUIT NOTICE: Lose Money on Elevance Health, Inc.? BFA Law Alerts Investors that the Class Action Could Allow Investors to Recover Losses (NYSE:ELV)
Published: June 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Read More
ELV STOCK NOTICE: Elevance Health, Inc. has been Sued for Fraud; Investors are Notified to Contact BFA Law before July 11 Legal Deadline
Published: June 03, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 3, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Read More
ELV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elevance Health, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
Published: June 03, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Elevance securities between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period").
Read More
ROSEN, HIGHLY RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ELV
Published: June 02, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / June 2, 2025 / WHY: New York, N.Y., June 2, 2025.
Read More
ELV STOCK ALERT: Elevance Health, Inc. Shareholders with Losses may have been Affected by Fraud - Contact BFA Law
Published: June 02, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
Published: June 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
Deadline Alert: Elevance Health, Inc. (ELV) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Published: June 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, June 02, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the “Class Period”).
Read More
ELV STOCK: Suffer Losses on Elevance Health, Inc.? BFA Law Notifies Investors of Imminent July 11 Securities Class Action Deadline (NYSE:ELV)
Published: June 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Read More
ELV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elevance Health, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
Published: June 02, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Elevance securities between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period").
Read More
ELV Shareholders Have the Right to Lead the Elevance Health, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV
Published: June 02, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , June 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE: ELV) for violations of the federal securities laws. Shareholders who purchased the Company's securities between April 18, 2024 and October 16, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 11, 2025.
Read More
ROSEN, A LONGSTANDING FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ELV
Published: June 01, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE:ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period"), of the important July 11, 2025 lead plaintiff deadline. SO WHAT: If you purchased Elevance common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV
Published: June 01, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.
Read More
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit
Published: May 30, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , May 30, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period"), of the important July 11, 2025 lead plaintiff deadline. So what: If you purchased Elevance Health common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
ELV DEADLINE REMINDER: Elevance Health, Inc. Investors May Be Able to Recover Losses - Contact BFA Law by July 11 Class Action Deadline
Published: May 30, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 30, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Read More
ELV Investors Have the Opportunity to Lead the Elevance Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Published: May 30, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elevance To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Elevance between April 18, 2024 and October 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , May 30, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Elevance Health, Inc. ("Elevance" …
Read More
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV
Published: May 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.
Read More
About Elevance Health Inc. (ELV)
- IPO Date 2001-10-30
- Website https://www.elevancehealth.com
- Industry Medical - Healthcare Plans
- CEO Gail Koziara Boudreaux
- Employees 104200